re: Ann: FDA Approval Of New Dual-Scored 150m...
Please help!
I have been looking for undervalued pharma stocks and come across this beauty.
Seems like a massive bargain to me, what is the catch here?
I see that they have drugs that they are selling and more to come soon with "SUBACAP" this subacap looks very good and will add to the excellent products that the company already has!
Looks like they have been overlooked by the market, lots of small phama companies getting pumped now with market caps half of MYX and IMO they all would love to be where this co is now with cash coming in from product sales. So I ask again what is holding Mayne Pharma back???
Sorry to maybe put this co of the rader of many if people are trying to load up but I really don't like losing money, could any holders tell me what's holding MYX back?
Thanks in advance for any replys
http://www.asx.com.au/asxpdf/20111123/pdf/422qtkpfj199p7.pdf
http://www.maynepharma.com
Ann: FDA Approval Of New Dual-Scored 150mg Doryx , page-5
Add MYX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$4.60 |
Change
-0.170(3.56%) |
Mkt cap ! $391.3M | |||
| Open | High | Low | Value | Volume |
| $4.71 | $4.73 | $4.57 | $511.7K | 110.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 520 | $4.60 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $4.63 | 562 | 1 |
View Market Depth
| Last trade - 16.10pm 02/10/2024 (20 minute delay) ? |
| MYX (ASX) Chart |